Trinity Biotech plc
TRIB · NASDAQ
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | $52,152 | $62,363 | $57,129 | $104,121 |
| - Cash | $4,066 | $5,167 | $2,840 | $5,317 |
| + Debt | $107,970 | $100,764 | $93,715 | $93,335 |
| Enterprise Value | $156,056 | $157,960 | $148,004 | $192,139 |
| Revenue | $7,576 | $15,857 | $15,152 | $15,843 |
| % Growth | -52.2% | 4.7% | -4.4% | – |
| Gross Profit | $1,566 | $4,877 | $5,308 | $5,734 |
| % Margin | 20.7% | 30.8% | 35% | 36.2% |
| EBITDA | -$5,848 | -$9,598 | -$1,112 | -$3,899 |
| % Margin | -77.2% | -60.5% | -7.3% | -24.6% |
| Net Income | -$8,804 | -$16,956 | -$4,759 | -$6,757 |
| % Margin | -116.2% | -106.9% | -31.4% | -42.6% |
| EPS Diluted | -0.48 | -1.2 | -0.46 | -0.71 |
| % Growth | 60% | -160.9% | 35.2% | – |
| Operating Cash Flow | -$2,962 | $3,351 | -$3,624 | -$1,100 |
| Capital Expenditures | -$56 | -$2,736 | -$2,699 | -$3,167 |
| Free Cash Flow | -$3,018 | $615 | -$6,323 | -$4,267 |